Cargando…
The clinical relevance of animal models in Sjögren’s syndrome: the interferon signature from mouse to man
Mouse models have been widely used to elucidate the pathogenic mechanisms of human diseases. The advantages of using these models include the ability to study different stages of the disease with particular respect to specific target organs, to focus on the role of specific pathogenic factors and to...
Autores principales: | Maria, Naomi I, Vogelsang, Petra, Versnel, Marjan A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490668/ https://www.ncbi.nlm.nih.gov/pubmed/26137972 http://dx.doi.org/10.1186/s13075-015-0678-2 |
Ejemplares similares
-
Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren’s Syndrome
por: Huijser, Erika, et al.
Publicado: (2021) -
Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression
por: Brkic, Zana, et al.
Publicado: (2013) -
Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine
por: Collins, Alexis, et al.
Publicado: (2021) -
MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome
por: Maria, Naomi I, et al.
Publicado: (2014) -
Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial
por: Bodewes, Iris L A, et al.
Publicado: (2020)